These final results, along with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 help the strategy of targeting ACKR3 as a unique approach to modulate the opioid method, which could open new therapeutic avenues for opioid-related disorders. “Over-all, the discovery of your https://ericl495duk1.illawiki.com/user